Total Payments
$3,696
2024 Payments
$773.17
Companies
29
Transactions
221
Medicare Patients
990
Medicare Billing
$54,332
Payment Breakdown by Category
Food & Beverage$3,673 (99.4%)
Education$22.94 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,673 | 220 | 99.4% |
| Education | $22.94 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $788.53 | 50 | $0 (2024) |
| Lilly USA, LLC | $685.98 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $387.75 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $297.65 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $239.46 | 12 | $0 (2024) |
| PFIZER INC. | $132.51 | 8 | $0 (2024) |
| Novo Nordisk Inc | $130.07 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $127.42 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $99.01 | 7 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $96.45 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $773.17 | 39 | ABBVIE INC. ($189.88) |
| 2023 | $1,158 | 74 | ABBVIE INC. ($301.37) |
| 2022 | $1,163 | 67 | ABBVIE INC. ($237.53) |
| 2021 | $602.39 | 41 | Lilly USA, LLC ($120.30) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: VIROLOGY | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 70 | 79 | $2,895 | $1,405 |
| 2022 | 8 | 243 | 269 | $23,745 | $10,620 |
| 2021 | 8 | 342 | 459 | $49,225 | $23,502 |
| 2020 | 7 | 335 | 437 | $48,992 | $18,805 |
Total Patients
990
Total Services
1,244
Medicare Billing
$54,332
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 18 | 20 | $1,040 | $1,006 | 96.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 24 | $1,200 | $228.48 | 19.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 11 | $319.00 | $118.48 | 37.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 24 | $336.00 | $52.80 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 118 | $11,682 | $4,885 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 43 | $5,977 | $2,625 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $1,960 | $1,423 | 72.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 17 | 18 | $936.00 | $907.63 | 97.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $832.00 | $262.71 | 31.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 27 | $1,350 | $258.91 | 19.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $700.00 | $208.39 | 29.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 22 | 22 | $308.00 | $48.70 | 15.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 155 | $21,700 | $9,714 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 158 | $15,800 | $8,376 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $2,870 | $2,364 | 82.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 23 | 23 | $4,600 | $1,606 | 34.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 23 | $1,495 | $789.32 | 52.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 22 | 22 | $1,070 | $330.88 | 30.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 20 | 26 | $1,300 | $252.46 | 19.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 25 | 30 | $390.00 | $67.50 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 131 | 194 | $27,110 | $10,731 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 109 | 138 | $13,800 | $4,791 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $1,610 | $1,419 | 88.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 22 | 22 | $4,400 | $1,389 | 31.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 14 | 14 | $630.00 | $206.60 | 32.8% |
About Kirby Stacks, NP-C
Kirby Stacks, NP-C is a Family healthcare provider based in Seymour, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1841606951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kirby Stacks, NP-C has received a total of $3,696 in payments from pharmaceutical and medical device companies, with $773.17 received in 2024. These payments were reported across 221 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,673).
As a Medicare-enrolled provider, Stacks has provided services to 990 Medicare beneficiaries, totaling 1,244 services with total Medicare billing of $54,332. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Seymour, IN
- Active Since 07/09/2014
- Last Updated 11/14/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1841606951
Products in Payments
- VRAYLAR (Drug) $315.96
- UBRELVY (Drug) $314.97
- TRELEGY ELLIPTA (Drug) $246.59
- EMGALITY (Drug) $230.68
- MOUNJARO (Drug) $210.69
- TRULICITY (Drug) $169.83
- BEVESPI AEROSPHERE (Drug) $144.06
- LEQVIO (Drug) $134.60
- ELIQUIS (Drug) $119.87
- QULIPTA (Drug) $117.67
- FARXIGA (Drug) $106.65
- ENTRESTO (Drug) $104.86
- Kerendia (Drug) $96.45
- Dexcom G6 Transmitter (Medical Supply) $83.48
- JARDIANCE (Drug) $74.78
- XIFAXAN (Drug) $68.02
- GARDASIL 9 (Biological) $64.92
- TRADJENTA (Drug) $59.82
- Auvelity (Drug) $56.67
- Vascepa (Drug) $54.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Seymour
Elizabeth Tape, N.p, N.P
Family — Payments: $7,586
Family $7,586
Brittany Simpson, Fnp, FNP
Family — Payments: $6,157
Family $6,157
Ms. Tara Pearcy, Aprn, APRN
Family — Payments: $5,227
Family $5,227
Ms. Erin Stuckwish, Fnp, FNP
Family — Payments: $4,144
Family $4,144
Mrs. Brandi Phillips, Aprn, APRN
Family — Payments: $3,546
Family $3,546
Mrs. Andrea Keane, Np, NP
Family — Payments: $3,358
Family $3,358